Enter your login e-mail to the account
Search
- The role of targeted therapy in the treatment of renal cell carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(11/2009, Review articles ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- Tumors of the central nervous system in children
MUDr. Zdeněk Pavelka, MUDr. Karel Zitterbart
(1/2011, From the boundary of neurology ) - Neurofibromatosis von Recklinghausen typ 1 (NF1) – nejčastější onemocnění ze skupiny neurokutánních chorob
MUDr. Bořivoj Petrák, CSc., MUDr. Marie Glombová
(2/2018, Main topic )
- Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - Pheochromocytoma and paraganglioma
MUDr. Mária Rečková
(2/2013, Main topic ) - RNDr. Gabriel Minárik, PhD.
RNDr. Gabriel Minárik, PhD.
(5/2014, Main topic ) - The role of targeted therapy in the treatment of renal cell carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(5/2009, Review articles ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic )